Cigna key statistics and ratios
In fiscal 2025, Cigna had return on equity of 14.4%, an operating margin of 3.3%, debt equal to 75.4% of equity and a current ratio of 0.85. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 93.8% | 94.1% | 90.1% | 36.4% | 35.5% | 32.5% | 30.8% | 31.5% | 26.1% | 21.8% | 20.6% |
| Operating margin | 7.8% | 9.4% | 8.6% | 5.3% | 5.1% | 4.6% | 4.7% | 4.4% | 3.8% | 3.3% | 3.5% |
| Net margin | 4.7% | 5.4% | 5.4% | 3.3% | 5.3% | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% | 2.3% |
| Free-cash-flow margin | 8.9% | 8.6% | 6.7% | 5.5% | 6.5% | 4.1% | 4.8% | 6.0% | 4.2% | 3.5% | 3.6% |
| Return on equity | 13.6% | 16.3% | 9.6% | 11.8% | 17.7% | 11.0% | 14.6% | 11.4% | 7.9% | 14.4% | 15.2% |
| Return on assets | — | 3.6% | 2.5% | 3.3% | 5.4% | 3.5% | 4.5% | 3.5% | 2.2% | 3.8% | 4.1% |
| Asset turnover | — | 0.68 | 0.45 | 0.99 | 1.03 | 1.12 | 1.21 | 1.32 | 1.60 | 1.75 | 1.79 |
| Current ratio | — | 0.85 | 0.64 | 0.74 | 0.77 | 0.83 | 0.73 | 0.77 | 0.84 | 0.85 | 0.85 |
| Debt to equity | 0.0% | 39.7% | 103.5% | 82.5% | 65.4% | 71.5% | 69.6% | 66.9% | 77.9% | 75.4% | 74.8% |
| Interest cover (operating income ÷ interest) | 12.3x | 16.2x | 8.2x | 5.0x | 5.8x | 6.1x | 6.5x | 6.1x | 6.3x | 6.6x | 7.2x |
| Effective tax rate | 38.1% | 38.1% | 26.1% | 22.1% | 21.9% | 20.2% | 19.2% | 2.6% | 28.3% | 19.2% | 19.2% |
| SG&A as % of revenue | 24.6% | 24.0% | 24.5% | 9.2% | 8.8% | 7.5% | 7.3% | 7.6% | 6.0% | 5.3% | 5.0% |
| Capital spending as % of revenue | 1.2% | 1.1% | 1.1% | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Free cash flow ÷ net income | 190.9% | 161.6% | 122.9% | 165.3% | 122.4% | 133.9% | 129.1% | 228.8% | 301.8% | 161.2% | 160.2% |
| Dividends ÷ net income | — | — | — | 0.3% | 0.2% | 25.0% | 20.6% | 28.1% | 45.6% | 27.0% | 25.3% |
| Dividends and buybacks ÷ free cash flow | 3.9% | 75.4% | 10.5% | 23.7% | 39.2% | 126.3% | 103.9% | 31.6% | 83.0% | 54.5% | 28.3% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 25.3% | 25.3% | 26.1% | 20.7% | 20.4% | 20.3% | 21.0% | 20.9% |
| Operating margin | 4.0% | 3.3% | 3.0% | 3.4% | 3.7% | 3.2% | 3.4% | 3.7% |
| Net margin | 1.2% | 2.2% | 2.0% | 2.3% | 2.7% | 1.7% | 2.4% | 2.3% |
| Free-cash-flow margin | 0.1% | 7.9% | 2.9% | −2.8% | 4.9% | 8.5% | 1.7% | −0.6% |
| Current ratio | 0.86 | 0.84 | 0.78 | 0.79 | 0.83 | 0.85 | 0.82 | 0.85 |
| Debt to equity | 77.9% | 77.9% | 75.7% | 76.5% | 81.4% | 75.4% | 73.2% | 74.8% |
| SG&A as % of revenue | 5.6% | 5.9% | 6.4% | 5.1% | 4.8% | 5.0% | 5.4% | 4.8% |
Financial health
- Short-term assets cover short-term liabilities $47.0bn of assets due within a year against $55.6bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $47.0bn short-term assets against $58.6bn of longer-dated liabilities.
- More cash than debt $6.3bn of cash against $31.9bn of debt.
- Debt below 40% of shareholders' equity Debt is 75% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 66% to 75% over five years.
- A year's operating cash flow covers at least 20% of debt $10.3bn of operating cash flow against $31.9bn of debt.
- Operating profit covers interest at least five times over Operating income of $10.0bn against $1.4bn of interest.
Moat
Moderate moat
How hard Cigna's competitive advantage looks for rivals to wear away, judged from 8 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 27.4% of total assets over 7 years.
- Pricing power 6 / 20
Gross margin has been a median 31.3%, moving by 7.9 percentage points (standard deviation) across 8 years.
- Durability 10 / 20
Operating margin has been a median 4.4%; its worst year was 3.4%.
- Cash conversion 12 / 20
Free cash flow was positive in 8 of 8 years, at a median 3.3% of revenue.
- Discipline 15 / 20
The diluted share count fell 25.5% over five years.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (62 before it).
Compare with peers
- CVS Health statistics
- Brightspring Health Services, Inc. statistics
- Labcorp statistics
- DaVita statistics
- Quest Diagnostics statistics
Head to head: CI vs CVSBTSG vs CICI vs LH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies